Skip to main content
search

Roche licenses Ionis’ Antisense HD Therapy following groundbreaking trial

By 14.12.2017September 17th, 2020Features

Share this article

View all news

Sign up to receive our newsletter in your inbox.

Sign up

You May Also Like

AllFeatures FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund

FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund

lenka
lenka29.02.2024
AllFeatures Synendos Therapeutics granted EMA clinical trial authorisation

Synendos Therapeutics granted EMA clinical trial authorisation

lenka
lenka18.01.2024
AllFeatures William Pao joins Alentis Therapeutics as independent board member

William Pao joins Alentis Therapeutics as independent board member

lenka
lenka09.01.2024
Close Menu